drugset / Trial / NCT06674577
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to collect long-term safety and tolerability data for atacicept in patients with IgAN that completed Vera trial investigating atacicept in IgAN population.
Timeline
- Start
- 2024-12-01
- Primary completion
- 2031-05-21
- Completion
- 2031-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atacicept | Protein / enzyme biologic | 150 mg | Subcutaneous |